C07K 14/501
Acidic fgf [afgf]
Official title: {acidic FGF [aFGF]}
C07K14/501 (Acidic fgf [afgf]) appears on 118 US grants and 92 published applications in this corpus.
Search patents in C07K- Granted patents
- 118
- Published applications
- 92
- Assignees
- 62
- Inventors
- 203
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 5 | 0 |
| 1994 | 2 | 0 |
| 1995 | 6 | 0 |
| 1996 | 5 | 0 |
| 1997 | 6 | 0 |
| 1998 | 8 | 0 |
| 1999 | 3 | 0 |
| 2000 | 5 | 0 |
| 2001 | 2 | 2 |
| 2002 | 2 | 5 |
| 2003 | 2 | 4 |
| 2004 | 2 | 5 |
| 2005 | 2 | 3 |
| 2006 | 3 | 2 |
| 2007 | 7 | 4 |
| 2008 | 1 | 1 |
| 2009 | 4 | 7 |
| 2010 | 8 | 2 |
| 2011 | 1 | 0 |
| 2012 | 6 | 2 |
| 2013 | 2 | 6 |
| 2014 | 2 | 3 |
| 2015 | 2 | 5 |
| 2016 | 4 | 3 |
| 2017 | 3 | 11 |
| 2018 | 7 | 5 |
| 2019 | 2 | 5 |
| 2020 | 3 | 2 |
| 2021 | 1 | 2 |
| 2022 | 4 | 1 |
| 2023 | 1 | 3 |
| 2024 | 0 | 3 |
| 2025 | 0 | 2 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant modified fibroblast growth factors and therapeutic uses thereof14 Apr 2026US 12,600,756 B2Trefoil Therapeutics, Inc.
- Synthetic foldable proteins generated from peptide segments of folding nuclei of reference proteins24 Mar 2026US 12,583,897 B2The Florida State University Research Foundation, Inc.
- Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose3 Jan 2023US 11,542,309 B2The Salk Institute for Biological Studies
- Synthetic foldable proteins generated from peptide segments of folding nuclei of reference proteins25 Oct 2022US 11,479,590 B2The Florida State University Research Foundation, Inc.
- Recombinant modified fibroblast growth factors and therapeutic uses thereof25 Oct 2022US 11,479,591 B2Trefoil Therapeutics, Inc.
- Recombinant modified fibroblast growth factors and therapeutic uses thereof10 Sep 2026US 2026/0265323 A1Trefoil Therapeutics, Inc.
- Sfgf1-fgf21: a chimeric protein with increased stability and biological activities27 Aug 2026US 2026/0250340 A1
- Caviar polypeptides23 Apr 2026US 2026/0108449 A1
- Cell cultivation processes for preparing food products, products provided by said processes and a system for providing these processes19 Feb 2026US 2026/0049281 A1BTL Healthcare Technologies A.S.
- Recombinant production of growth factors in algae for cell culture applications27 Nov 2025US 2025/0361278 A1Phycin Inc.
Most cited
By later US patents
- Supplemented and unsupplemented tissue sealants, methods of their production and use441US 6,197,325 B1American National Red Cross · 2001
- Supplemented and unsupplemented tissue sealants, methods of their production and use292US 6,054,122 AAmerican National Red Cross · 2000
- Cationic lipids and the use thereof249US 5,830,430 AImaRx Pharmaceutical Corp. · 1998
- Supplemented and unsupplemented tissue sealants, method of their production and use190US 6,117,425 AAmerican National Red Cross · 2000
- Method of preparing a tissue sealant-treated biomedical material177US 6,559,119 B1American National Red Cross · 2003